title: A survey describing the use of complementary therapies and medicines by women attending a family planning clinic.
abstract: BACKGROUND
  Complementary medicines (CMs) are widely used by women. Although, women in Australia are frequent users of CM, few studies have examined their utilisation by women attending a family planning service. The aim of this study was to examine (i) the extent of and type of CM, (ii) women's views about safety and efficacy, and (iii) the factors influencing women's decision-making.
  
  
  METHODS
  A cross-sectional survey using a convenience sample of 221 women aged greater than 18 years attending a family planning (FP) service was undertaken over a two week period in Sydney, Australia. An anonymous self-administered questionnaire was designed to examine women's current and previous use of CMs, their attitudes towards safety and effectiveness, the factors influencing their decision-making, and their disclosure of CM use to a FP health professional. Demographic questions were designed to describe the diversity of the participants. Logistic regression was used to examine the association between CM use and demographics.
  
  
  RESULTS
  Sixty-seven percent of women surveyed were currently using CMs, and 83% reported use during the previous 12 months. Most respondents utilised CMs to maintain their general health or for prevention of ill health. Over 30% of women lacked information to make an informed response to questions examining their views about the safety of CMs. Forty-four percent of participants stated they discussed their use of CMs with their FP providers. The main reason why women did not mention CMs was they did not see the relevance to their consultation (43%). Lower rates of CM use were found for younger women (OR 0.24, 95% CI 0.09-0.61), and those not completing high school (OR 0.44, 95% 0.20-1.00).
  
  
  CONCLUSIONS
  The use of CM is very common among women attending an Australian FP clinic, however our findings may not be generalisable to all women. We identified a notable gap in women's awareness of the potential for interactions between CM and prescribed medication. Our findings also emphasise the need for healthcare providers to initiate discussions with clients about their utilisation of CM.
authors.affiliation: Centre for Complementary Medicine Research, University of Western Sydney, Penrith, Australia. caroline.smith@uws.edu.au.
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Smith
authors.forename: Deborah J
authors.initials: DJ
authors.lastname: Bateson
authors.forename: Edith
authors.initials: E
authors.lastname: Weisberg
mesh_terms: D000293:Adolescent; D000328:Adult; D000529:Complementary Therapies / Q000706:statistics & numerical data*; D003430:Cross-Sectional Studies; D005193:Family Planning Services / Q000706:statistics & numerical data*; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008875:Middle Aged; D012044:Regression Analysis; D011795:Surveys and Questionnaires; D055815:Young Adult
references.citation: Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):371-80
references.pmid: 15170766
references.citation: Birth. 2011 Sep;38(3):200-6
references.pmid: 21884228
references.citation: J Altern Complement Med. 2007 Jul-Aug;13(6):643-50
references.pmid: 17718647
references.citation: Evid Based Complement Alternat Med. 2010 Dec;7(4):477-86
references.pmid: 18955336
references.citation: Br J Clin Pharmacol. 2003 Dec;56(6):683-90
references.pmid: 14616430
references.citation: Altern Ther Health Med. 2011 Mar-Apr;17(2):50-9
references.pmid: 21717826
references.citation: Contraception. 2005 Jun;71(6):402-8
references.pmid: 15914127
references.citation: JAMA. 1998 Nov 11;280(18):1569-75
references.pmid: 9820257
references.citation: J Am Med Womens Assoc (1972). 2004 Winter;59(1):17-24
references.pmid: 14768981
references.citation: J Altern Complement Med. 2011 Aug;17(8):685-90
references.pmid: 21732824
references.citation: J Midwifery Womens Health. 2010 Jul-Aug;55(4):335-43
references.pmid: 20630360
references.citation: Clin Pharmacol Ther. 2003 Dec;74(6):525-35
references.pmid: 14663455
references.citation: Arch Intern Med. 2002 Feb 11;162(3):281-7
references.pmid: 11822920
references.citation: Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):151-9
references.pmid: 17992658
references.citation: Aust N Z J Obstet Gynaecol. 2007 Apr;47(2):145-9
references.pmid: 17355306
references.citation: J Obstet Gynaecol. 2011;31(1):59-61
references.pmid: 21280996
references.citation: Br J Clin Pharmacol. 2003 Jan;55(1):112-3
references.pmid: 12534648